Edgotype: A fundamental link between genotype and phenotype

Current Opinion in Genetics and Development

Volumn 23, Issue 6, 2013, Pages 649-657

  Sahni, Nidhi ^a,b   Yi, Song ^a,b   Zhong, Quan ^a,b   Jailkhani, Noor ^a,b   Charloteaux, Benoit ^a,b   Cusick, Michael E ^a,b   Vidal, Marc ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; NOTCH RECEPTOR; PDZ PROTEIN; PROTEIN KINASE B; PROTEIN SH2; PROTEIN SH3;

AEC SYNDROME; BINDING SITE; EDGOTYPE; EEC SYNDROME; GENE FUNCTION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEREDITY; HUMAN; MISSENSE MUTATION; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN STRUCTURE; REVERSE GENETICS; REVIEW; RNA BINDING; SITE DIRECTED MUTAGENESIS; STOP CODON;

GENE REGULATORY NETWORKS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, GENETIC; MUTATION; PHENOTYPE; PROTEIN INTERACTION DOMAINS AND MOTIFS;

EID: 84889606541     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2013.11.002     Document Type: Review

References (99)

1. Beadle G.W., Tatum E.L. Genetic control of biochemical reactions in Neurospora. Proc Natl Acad Sci USA 1941, 27:499-506.
2. Fearon E.R. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997, 278:1043-1050.
3. Weatherall D.J. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2001, 2:245-255.
4. Perlis R.H., Smoller J.W., Mysore J., Sun M., Gillis T., Purcell S., Rietschel M., Nothen M.M., Witt S., Maier W., et al. Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. Am J Psychiatry 2010, 167:574-579.
5. Visscher P.M., Brown M.A., McCarthy M.I., Yang J. Five years of GWAS discovery. Am J Hum Genet 2012, 90:7-24.
6. Majewski J., Rosenblatt D.S. Exome and whole-genome sequencing for gene discovery: the future is now!. Hum Mutat 2012, 33:591-592.
7. Vidal M., Cusick M.E., Barabási A.L. Interactome networks and human disease. Cell 2011, 144:986-998.
8. Barabási A.L., Oltvai Z.N. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004, 5:101-113.
9. Ideker T., Sharan R. Protein networks in disease. Genome Res 2008, 18:644-652.
10. Kahle J.J., Gulbahce N., Shaw C.A., Lim J., Hill D.E., Barabási A.L., Zoghbi H.Y. Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia. Hum Mol Genet 2011, 20:510-527.
11. Lim J., Crespo-Barreto J., Jafar-Nejad P., Bowman A.B., Richman R., Hill D.E., Orr H.T., Zoghbi H.Y. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 2008, 452:713-718.
12. Lim J., Hao T., Shaw C., Patel A.J., Szabo G., Rual J.F., Fisk C.J., Li N., Smolyar A., Hill D.E., et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006, 125:801-814.
13. Sakai Y., Shaw C.A., Dawson B.C., Dugas D.V., Al-Mohtaseb Z., Hill D.E., Zoghbi H.Y. Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med 2011, 3:ra49.
14. Kaltenbach L.S., Romero E., Becklin R.R., Chettier R., Bell R., Phansalkar A., Strand A., Torcassi C., Savage J., Hurlburt A., et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet 2007, 3:e82.
15. Goehler H., Lalowski M., Stelzl U., Waelter S., Stroedicke M., Worm U., Droege A., Lindenberg K.S., Knoblich M., Haenig C., et al. A protein interaction network links GIT1, an enhancer of Huntingtin aggregation, to Huntington's disease. Mol Cell 2004, 15:853-865.
16. Pujana M.A., Han J.D., Starita L.M., Stevens K.N., Tewari M., Ahn J.S., Rennert G., Moreno V., Kirchhoff T., Gold B., et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007, 39:1338-1349.
17. Maxwell C.A., Benitez J., Gómez-Baldó L., Osorio A., Bonifaci N., Fernández-Ramires R., Costes S.V., Guinó E., Chen H., Evans G.J., et al. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol 2011, 9:e1001199.
18. Taylor I.W., Linding R., Warde-Farley D., Liu Y., Pesquita C., Faria D., Bull S., Pawson T., Morris Q., Wrana J.L. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 2009, 27:199-204.
19. Zhong Q., Simonis N., Li Q.R., Charloteaux B., Heuze F., Klitgord N., Tam S., Yu H., Venkatesan K., Mou D., et al. Edgetic perturbation models of human inherited disorders. Mol Syst Biol 2009, 5:321.
20. Schuster-Bockler B., Bateman A. Protein interactions in human genetic diseases. Genome Biol 2008, 9:R9.
21. Botstein D., Risch N. Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease. Nat Genet 2003, 33:228-237.
22. Raj A., Rifkin S.A., Andersen E., van Oudenaarden Variability in gene expression underlies incomplete penetrance. Nature 2010, 463:913-918.
23. Chakravarti A., Clark A.G., Mootha V.K. Distilling pathophysiology from complex disease genetics. Cell 2013, 155:21-26.
24. Wang X., Wei X., Thijssen B., Das J., Lipkin S.M., Yu H. Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol 2012, 30:159-164.
25. Csermely P., Korcsmaros T., Kiss H.J., London G., Nussinov R. Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther 2013, 138:333-408.
26. Braun P. Interactome mapping for analysis of complex phenotypes: insights from benchmarking binary interaction assays. Proteomics 2012, 12:1499-1518.
27. Gingras A.C., Raught B. Beyond hairballs: the use of quantitative mass spectrometry data to understand protein-protein interactions. FEBS Lett 2012, 586:2723-2731.
28. Chien C.T., Bartel P.L., Sternglanz R., Fields S. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci USA 1991, 88:9578-9582.
29. Dreze M., Monachello D., Lurin C., Cusick M.E., Hill D.E., Vidal M., Braun P. High-quality binary interactome mapping. Methods Enzymol 2010, 470:281-315.
30. Walzthoeni T., Leitner A., Stengel F., Aebersold R. Mass spectrometry supported determination of protein complex structure. Curr Opin Struct Biol 2013, 23:252-260.
31. Rual J.F., Venkatesan K., Hao T., Hirozane-Kishikawa T., Dricot A., Li N., Berriz G.F., Gibbons F.D., Dreze M., Ayivi-Guedehoussou N., et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005, 437:1173-1178.
32. Stelzl U., Worm U., Lalowski M., Haenig C., Brembeck F.H., Goehler H., Stroedicke M., Zenkner M., Schoenherr A., Koeppen S., et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122:957-968.
33. Giot L., Bader J.S., Brouwer C., Chaudhuri A., Kuang B., Li Y., Hao Y.L., Ooi C.E., Godwin B., Vitols E., et al. A protein interaction map of Drosophila melanogaster. Science 2003, 302:1727-1736.
34. Li S., Armstrong C.M., Bertin N., Ge H., Milstein S., Boxem M., Vidalain P.O., Han J.D., Chesneau A., Hao T., et al. A map of the interactome network of the metazoan C. elegans. Science 2004, 303:540-543.
35. Yu H., Braun P., Yildirim M.A., Lemmons I., Venkatesan K., Sahalie J., Hirozane-Kishikawa T., Gebreab F., Li N., Simonis N., et al. High quality binary protein interaction map of the yeast interactome network. Science 2008, 322:104-110.
36. Evidence for network evolution in an Arabidopsis interactome map. Science 2011, 333:601-607. Arabidopsis Interactome Mapping Consortium.
37. Das J., Vo T.V., Wei X., Mellor J.C., Tong V., Degatano A.G., Wang X., Wang L., Cordero N.A., Kruer-Zerhusen N., et al. Cross-species protein interactome mapping reveals species-specific wiring of stress response pathways. Sci Signal 2013, 6:ra38.
38. Venkatesan K., Rual J.F., Vazquez A., Stelzl U., Lemmens I., Hirozane-Kishikawa T., Hao T., Zenkner M., Xin X., Goh K.I., et al. An empirical framework for binary interactome mapping. Nat Methods 2009, 6:83-90.
39. Braun P., Tasan M., Dreze M., Barrios-Rodiles M., Lemmens I., Yu H., Sahalie J.M., Murray R.R., Roncari L., De Smet A.-S., et al. An experimentally derived confidence score for binary protein-protein interactions. Nat Methods 2009, 6:91-97.
40. Cusick M.E., Yu H., Smolyar A., Venkatesan K., Carvunis A.R., Simonis N., Rual J.F., Borick H., Braun P., Dreze M., et al. Literature-curated protein interaction datasets. Nat Methods 2009, 6:39-46.
41. Simonis N., Rual J.F., Carvunis A.R., Tasan M., Lemmons I., Hirozane-Kishikawa T., Hao T., Sahalie J.M., Venkatesan K., Gebreab F., et al. Empirically-controlled mapping of the Caenorhabditis elegans protein-protein interactome network. Nat Methods 2009, 6:47-54.
42. Jäger S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., Shales M., Mercenne G., Pache L., Li K., et al. Global landscape of HIV-human protein complexes. Nature 2011, 481:365-370.
43. Charloteaux B., Zhong Q., Dreze M., Cusick M.E., Hill D.E., Vidal M. Protein-protein interactions and networks: forward and reverse edgetics. Methods Mol Biol 2011, 759:197-213.
44. Ferrer-Costa C., Orozco M., de la Cruz X. Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties. J Mol Biol 2002, 315:771-786.
45. Yue P., Li Z., Moult J. Loss of protein structure stability as a major causative factor in monogenic disease. J Mol Biol 2005, 353:459-473.
46. Guo Y., Wei X., Das J., Grimson A., Lipkin S.M., Clark A.G., Yu H. Dissecting disease inheritance modes in a three-dimensional protein network challenges the "guilt-by-association" principle. Am J Hum Genet 2013.
47. Ong K.R., Woodward E.R., Killick P., Lim C., Macdonald F., Maher E.R. Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat 2007, 28:143-149.
48. Nordstrom-O'Brien M., van der Luijt R.B., van Rooijen E., van den Ouweland A.M., Majoor-Krakauer D.F., Lolkema M.P., van Brussel A., Voest E.E., Giles R.H. Genetic analysis of von Hippel-Lindau disease. Hum Mutat 2010, 31:521-537.
49. Strachan T.R., Reid A. Human Molecular Genetics 1999, John Wiley & Sons Inc, New York. edn 2.
50. Coffill C.R., Muller P.A., Oh H.K., Neo S.P., Hogue K.A., Cheok C.F., Vousden K.H., Lane D.P., Blackstock W.P., Gunaratne J. Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion. EMBO Rep 2012, 13:638-644.
51. DeCaprio J.A. How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40. Virology 2009, 384:274-284.
52. White E.A., Howley P.M. Proteomic approaches to the study of papillomavirus-host interactions. Virology 2013, 435:57-69.
53. Rozenblatt-Rosen O., Deo R.C., Padi M., Adelmant G., Calderwood M.A., Rolland T., Grace M., Dricot A., Askenazi M., Tavares M., et al. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 2012, 487:491-495.
54. Jager S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., Shales M., Mercenne G., Pache L., Li K., et al. Global landscape of HIV-human protein complexes. Nature 2011, 481:365-370.
55. White E.A., Kramer R.E., Tan M.J., Hayes S.D., Harper J.W., Howley P.M. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity. J Virol 2012, 86:13174-13180.
56. Tan M.J., White E.A., Sowa M.E., Harper J.W., Aster J.C., Howley P.M. Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proc Natl Acad Sci USA 2012.
57. Brimer N., Lyons C., Wallberg A.E., Vande Pol S.B. Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signalling. Oncogene 2012, 31:4639-4640.
58. Fine D.A., Rozenblatt-Rosen O., Padi M., Korkhin A., James R.L., Adelmant G., Yoon R., Guo L., Berrios C., Zhang Y., et al. Identification of FAM111A as an SV40 host range restriction and adenovirus helper factor. PLoS Pathog 2012, 8:e9491002.
59. Gulbahce N., Yan H., Dricot A., Padi M., Byrdsong D., Franchi R., Lee D.-S., Rozenblatt-Rosen O., Mar J.C., Calderwood M.A., et al. Viral perturbations of host networks reflect disease etiology. PLoS Comput Biol 2012, 8:e531 1002.
60. Unger S., Gorna M.W., Le Bechec A., Do Vale-Pereira S., Bedeschi M.F., Geiberger S., Grigelioniene G., Horemuzova E., Lalatta F., Lausch E., et al. FAM111A mutations result in hypoparathyroidism and impaired skeletal development. Am J Hum Genet 2013.
61. Lehner B. Genotype to phenotype: lessons from model organisms for human genetics. Nat Rev Genet 2013, 14:168-178.
62. Festa F., Steel J., Bian X., Labaer J. High-throughput cloning and expression library creation for functional proteomics. Proteomics 2013, 13:1381-1390.
63. Suzuki Y., Kagawa N., Fujino T., Sumiya T., Andoh T., Ishikawa K., Kimura R., Kemmochi K., Ohta T., Tanaka S. A novel high-throughput (HTP) cloning strategy for site-directed designed chimeragenesis and mutation using the Gateway cloning system. Nucleic Acids Res 2005, 33:e109.
64. Kato S., Han S.Y., Liu W., Otsuka K., Shibata H., Kanamaru R., Ishioka C. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 2003, 100:8424-8430.
65. Furlong L.I. Human diseases through the lens of network biology. Trends Genet 2012, 29:150-159.
66. Pavlicev M., Wagner G.P. A model of developmental evolution: selection, pleiotropy and compensation. Trends Ecol Evol 2012, 27:316-322.
67. Amberg D.C., Basart E., Botstein D. Defining protein interactions with yeast actin in vivo. Nat Struct Biol 1995, 2:28-35.
68. Schwartz H., Alvares C.P., White M.B., Fields S. Mutation detection by a two-hybrid assay. Hum Mol Genet 1998, 7:1029-1030.
69. Vojtek A.B., Hollenberg S.M., Cooper J.A. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 1993, 74:205-214.
70. Young K., Lin S., Sun L., Lee E., Modi M., Hellings S., Husbands M., Ozenberger B., Franco R. Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. Nat Biotechnol 1998, 16:946-950.
71. Ishioka C., Ballester R., Engelstein M., Vidal M., Kassel J., The I., Bernards A., Gusella J.F., Friend S.H. A functional assay for heterozygous mutations in the GTPase activating protein related domain of the neurofibromatosis type 1 gene. Oncogene 1995, 10:841-847.
72. Shi H., Rojas R., Bonifacino J.S., Hurley J.H. The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain. Nat Struct Mol Biol 2006, 13:540-548.
73. De Nicolo A., Parisini E., Zhong Q., Dalla Palma M., Stoeckert K.A., Domchek S.M., Nathanson K.L., Caligo M.A., Vidal M., Cusick M.E., et al. Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del. Cancer Res 2009, 69:7030-7037.
74. Wang W., Zhong Q., Teng L., Bhatnagar N., Sharma B., Zhang X., Luther W., Haynes L.P., Burgoyne R.D., Vidal M., et al. Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma. Oncogene 2013, 10.1038/onc.2013.290.
75. Macias E., Jin A., Deisenroth C., Bhat K., Mao H., Lindstrom M.S., Zhang Y. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 2010, 18:231-243.
76. King B., Trimarchi T., Reavie L., Xu L., Mullenders J., Ntziachristos P., Aranda-Orgilles B., Perez-Garcia A., Shi J., Vakoc C., et al. The ubiquitin ligase FBXW7 modulates leukemia-Initiating cell activity by regulating MYC stability. Cell 2013, 153:1552-1560.
77. van Bokhoven H., Brunner H.G. Splitting p63. Am J Hum Genet 2002, 71:1-13.
78. Vidal M., Brachmann R.K., Fattaey A., Harlow E., Boeke J.D. Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc Natl Acad Sci USA 1996, 93:10315-10320.
79. Vidal M., Braun P., Chen E., Boeke J.D., Harlow E. Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proc Natl Acad Sci USA 1996, 93:10321-10330.
80. Dreze M., Charloteaux B., Milstein S., Vidalain P.O., Yildirim M.A., Zhong Q., Svrzikapa N., Romero V., Laloux G., Brasseur R., et al. 'Edgetic' perturbation of a C. elegans BCL-2 ortholog. Nat Methods 2009, 6:843-849.
81. Liddington R.C. Structural basis of protein-protein interactions. Methods Mol Biol 2004, 261:3-14.
82. Han J.H., Batey S., Nickson A.A., Teichmann S.A., Clarke J. The folding and evolution of multidomain proteins. Nat Rev Mol Cell Biol 2007, 8:319-330.
83. Pawson T., Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 2003, 300:445-452.
84. Bhattacharyya R.P., Remenyi A., Yeh B.J., Lim W.A. Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Annu Rev Biochem 2006, 75:655-680.
85. + channel deleted in Liddle's syndrome. EMBO J 1996, 15:2371-2380.
86. Guglielmi B., van Berkum N.L., Klapholz B., Bijma T., Boube M., Boschiero C., Bourbon H.M., Holstege F.C., Werner M. A high resolution protein interaction map of the yeast Mediator complex. Nucleic Acids Res 2004, 32:5379-5380.
87. Albers M., Kranz H., Kober I., Kaiser C., Klink M., Suckow J., Kern R., Koegl M. Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. Mol Cell Proteomics 2005, 4:205-213.
88. Boxem M., Maliga Z., Klitgord N., Li N., Lemmens I., Mana M., de Lichtervelde L., Mul J.D., van de Peut D., Devos M., et al. A protein domain-based interactome network for C. elegans early embryogenesis. Cell 2008, 134:534-545.
89. Pulichino A.M., Vallette-Kasic S., Couture C., Gauthier Y., Brue T., David M., Malpuech G., Deal C., Van Vliet G., De Vroede M., et al. Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 2003, 17:711-716.
90. Seto M.L., Lee S.J., Sze R.W., Cunningham M.L. Another TWIST on Baller-Gerold syndrome. Am J Med Genet 2001, 104:323-330.
91. Kelsey L., Flenniken A.M., Qu D., Funnell A.P., Pearson R., Zhou Y.Q., Voronina I., Berberovic Z., Wood G., Newbigging S., et al. ENU-induced mutation in the DNA-binding domain of KLF3 reveals important roles for KLF3 in cardiovascular development and function in mice. PLoS Genet 2013, 9:e6121003.
92. Dickerman B.K., White C.L., Chevalier C., Nalesso V., Charles C., Fouchecourt S., Guillou F., Viriot L., Sen G.C., Herault Y. Missense mutation in the second RNA binding domain reveals a role for Prkra (PACT/RAX) during skull development. PLoS ONE 2011, 6:e7 2853.
93. Lee Y., Hur I., Park S.Y., Kim Y.K., Suh M.R., Kim V.N. The role of PACT in the RNA silencing pathway. EMBO J 2006, 25:522-532.
94. Bubenik J.L., Driscoll D.M. Altered RNA binding activity underlies abnormal thyroid hormone metabolism linked to a mutation in selenocysteine insertion sequence-binding protein 2. J Biol Chem 2007, 282:34653-34660.
95. Carpten J.D., Faber A.L., Horn C., Donoho G.P., Briggs S.L., Robbins C.M., Hostetter G., Boguslawski S., Moses T.Y., Savage S., et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 2007, 448:439-444.
96. Simons M., Schwarz K., Kriz W., Miettinen A., Reiser J., Mundel P., Holthofer H. Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol 2001, 159:1069-1070.
97. Shono A., Tsukaguchi H., Kitamura A., Hiramoto R., Qin X.S., Doi T., Iijima K. Predisposition to relapsing nephrotic syndrome by a nephrin mutation that interferes with assembly of functioning microdomains. Hum Mol Genet 2009, 18:2943-2950.
98. Pineda-Alvarez D.E., Roessler E., Hu P., Srivastava K., Solomon B.D., Siple C.E., Fan C.M., Muenke M. Missense substitutions in the GAS1 protein present in holoprosencephaly patients reduce the affinity for its ligand, SHH. Hum Genet 2012, 131:301-310.
99. Dipple K.M., McCabe E.R. Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. Am J Hum Genet 2000, 66:1729-1730.